Table 1.
Survivor (n=36) | Nonsurvivor (n=41) | P | |
---|---|---|---|
Age, year | 62.8±9.9 | 63.5±10.0 | 0.71 |
Female/male sex (n) | 4/32 | 7/34 | 0.52 |
Diagnosis | |||
Squamous cell carcinoma (n) | 20 | 22 | 0.94 |
Adenocarcinoma (n) | 12 | 15 | |
Others (n) | 4 | 4 | |
Charlson comorbidity index | 8 (6-12) | 8 (6-11) | 0.90 |
Time of death after admission, day | NA | 6 (1-30) | |
CRP, mg/dl | 6.2 (0.1-39.7) | 16.1 (1.9-51.5) | <0.001 |
Albumin, g/dl | 3.3 (1.9-4.3) | 2.8 (1.8-4.1) | <0.001 |
CRP/albumin ratio | 2.4 (0.02-1.4) | 7 (0.36-22.7) | <0.001 |
Neutrophil/lymphocyte ratio | 6.7 (0.3-38.4) | 10.3 (0.3-65.4) | 0.10 |
PLR | 229 (15.00-697.4) | 234.4 (2.50-5215.80) | 0.36 |
CRP: C-reactive protein, NA: Not available, PLR: Platelet/lymphocyte ratio